| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |